BALAMINES.NS(BALAMINES.NS)
BALAMINES.NS
No analyst ratings available
No analyst price targets available for BALAMINES.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $18.02B | $23.61B | $27.54B |
| Low | $18.02B | $23.61B | $27.54B |
| High | $18.02B | $23.61B | $27.54B |
| EBITDA Avg | $4.10B | $5.37B | $6.26B |
| Low | $4.10B | $5.37B | $6.26B |
| High | $4.10B | $5.37B | $6.26B |
| EBIT Avg | $3.60B | $4.71B | $5.49B |
| Low | $3.60B | $4.71B | $5.49B |
| High | $3.60B | $4.71B | $5.49B |
| Net Income Avg | $1.63B | $2.58B | $3.19B |
| Low | $1.63B | $2.58B | $3.19B |
| High | $1.63B | $2.58B | $3.19B |
| EPS Avg | $50.40 | $79.80 | $98.40 |
| Low | $50.40 | $79.80 | $98.40 |
| High | $50.40 | $79.80 | $98.40 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |